Test Overview
Test Methodology

Alere iCup DX Pro2 - immunochromatography (competitive)

Test Usage

Performed at authorized locations by point of care operators. Includes: Amphetamines, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Methamphetamine, Opiates, Oxycodone, Methadone, and THC. Three tests that can assist in the detection of adulteration of the specimen are also included: creatinine, specific gravity, and oxidizing agent detection. The Alere ICup DX Pro2 is a qualitative urine drug screen and is for medical purposes only. It is not for pre-employment or legal testing purposes.

Reference Range *

Reference ranges are available in the Urine Drug Screen Alere iCup DX Pro 2 procedure located on the POC website: https://www.pathology.med.umich.edu/point-of-care

Test Limitations

• Please see the Urine Drug Screen Alere iCup DX Pro 2 procedure located on the POC website: https://www.pathology.med.umich.edu/point-of-care for drug specific detection levels and interferences.
•This test has been developed for testing urine samples only. No other fluids have been evaluated.
•Adulterated urine samples may produce erroneous results. Strong oxidizing agents such as bleach (hypochlorite) can oxidize drug analytes. If a sample is suspected of being adulterated, obtain a new sample in a different, unused cup.
• This test is a qualitative screening assay. It is not designed to determine the quantitative concentration of drugs or the level of intoxication.
• This assay provides only preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography- mass spectrometry (LC-MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgement should be applied to any drug test result, particularly when preliminary positive results are indicated.

Test Details
Analytic Time

5 minutes

Soft Order Code
PUDS2
MiChart Code
Urine Drug Screen (Drug 10), Point of Care
Laboratory
Point of Care
Section
Point of Care
Specimen Requirements
Collection Instructions

Collect freshly voided, untreated urine into a plastic urine cup.

Rejection Criteria
Adulterated urines should be discarded, and new urine sample in a new container should be collected for testing.
Normal Volume
30 mL
Minimum Volume
10 mL
Additional Information

For more test specific information, please refer to the test procedure found on the Michigan Medicine POC website: https://www.pathology.med.umich.edu/point-of-care

Billing
CPT Code
80305
LOINC
Creatinine urine adulteration (2161-8), specific gravity urine adulteration (2965-2), oxidant urine adulteration (58714-7), amphetamines (19343-3), barbiturates (19270-8), buprenorphine (91027-3), benzodiazepines (14316-4), cocaine (19359-9), methampheta
NY State Approved
No